# PYRIMETHAMINE
> **ANDA207127** · Abbreviated New Drug Application (Generic) · Sponsor: SANALUZ · Approved 2020-02-28
## Drug
- **FDA Application Number:** ANDA207127
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PYRIMETHAMINE
- **Generic name:** PYRIMETHAMINE
- **Active ingredients:** PYRIMETHAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANALUZ
- **Manufacturer:** DR.REDDYS LABORATORIES INC
- **First approval:** 2020-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207127)
---
*AI Analytics · CC0 1.0*